RBCM
Raub Brock Capital Management’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.2M | Sell |
22,123
-547
| -2% | -$426K | 3.76% | 11 |
|
|
2025
Q1 | $18.7M | Sell |
22,670
-1,340
| -6% | -$1.11M | 4.18% | 6 |
|
|
2024
Q4 | $18.5M | Buy |
24,010
+131
| +0.5% | +$101K | 3.94% | 11 |
|
|
2024
Q3 | $21.2M | Sell |
23,879
-734
| -3% | -$650K | 4.3% | 9 |
|
|
2024
Q2 | $22.3M | Sell |
24,613
-3,691
| -13% | -$3.34M | 4.87% | 4 |
|
|
2024
Q1 | $22M | Sell |
28,304
-3,773
| -12% | -$2.94M | 4.66% | 3 |
|
|
2023
Q4 | $18.7M | Sell |
32,077
-12,536
| -28% | -$7.31M | 3.92% | 10 |
|
|
2023
Q3 | $24M | Sell |
44,613
-2,144
| -5% | -$1.15M | 4.76% | 3 |
|
|
2023
Q2 | $21.9M | Sell |
46,757
-17,047
| -27% | -$7.99M | 4.12% | 9 |
|
|
2023
Q1 | $21.9M | Buy |
63,804
+1,769
| +3% | +$608K | 4.21% | 7 |
|
|
2022
Q4 | $22.7M | Sell |
62,035
-6,865
| -10% | -$2.51M | 4.64% | 4 |
|
|
2022
Q3 | $22.3M | Sell |
68,900
-4,367
| -6% | -$1.41M | 4.65% | 5 |
|
|
2022
Q2 | $23.8M | Buy |
+73,267
| New | +$23.8M | 4.53% | 5 |
|